Msaouel, P., Rupe, E. S., Chen, X., Kotecha, R. R., Rieke, D. T., McGregor, B. A., Daw, N. C., Fan, A. C., Knoche, E. M., Kyriakopoulos, C., Lalani, A. A., Merla, A., Voss, M. H., Reaume, M. N., Lazar, A. J., Solis, L. M., Lim, B., Tannir, N. M., Karki, M., Zacharias, N. M. (2026). Prospective clinical activity and preclinical basis of panitumumab-based EGFR blockade in SMARCB1-deficient renal medullary carcinoma (RMC): A collaborative multi-institutional study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4520